Harrow Health, Inc.

NASDAQ:HROW

37.98 (USD) • At close September 6, 2024
Bedrijfsnaam Harrow Health, Inc.
Symbool HROW
Munteenheid USD
Prijs 37.98
Beurswaarde 1,347,640,542
Dividendpercentage 0%
52-weken bereik 7.6 - 44.8
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Mark L. Baum J.D.
Website https://www.harrowinc.com

An error occurred while fetching data.

Over Harrow Health, Inc.

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics

Vergelijkbare Aandelen

Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc.

ORMP

2.35 USD

Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

VKTX

54.13 USD

Scholar Rock Holding Corporation logo

Scholar Rock Holding Corporation

SRRK

8.03 USD

XBiotech Inc. logo

XBiotech Inc.

XBIT

6.52 USD

Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc.

RPID

0.835 USD

Talkspace, Inc. logo

Talkspace, Inc.

TALK

1.79 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

8.2 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)